TORONTO and NEW YORK, Oct. 10, 2017 /CNW/ - AcuityAds Holdings Inc. (TSXV:AT) ("AcuityAds" or "Company"), a technology leader that provides targeted digital media solutions enabling advertisers to connect intelligently with audiences across video, mobile, social and online display campaigns, today announced that it received an order from a global pharmaceutical company totaling $750,000 CDN. This global pharmaceutical company will be running multiple digital advertising campaigns throughout the U.S. in the fourth quarter in support of a brand re-launch for one of their over-the-counter medicines.
AcuityAds acquired 140 Proof for its social signal-based mobile offering and acquired Visible Measures for its analytics-led video offering. The integrated company enables its sales force to provide a more powerful holistic solution and engage in expanded conversations with brands to capture a greater share of their digital advertising spend.
"This win highlights the expanded value proposition that we can offer marketers looking to garner real returns and those seeking a greater share of audience attention from their advertising initiatives," stated Tal Hayek, CEO of AcuityAds. "It also validates that we are seeing a significant increase in the average order size."
Additionally, the Company is pleased to announce that it was recently recognized as the fifth fastest growing Canadian software company in Canada and ranked #18 overall on the 2017 PROFIT 500 Ranking of Canada's Fastest Growing Companies.
AcuityAds is a technology company that enables marketers to connect intelligently with their most meaningful audiences through digital media. A Self-Serve programmatic marketing platform, powered by machine learning, is at the core of our business. This is accompanied by strategic digital advertising solutions that cater to social, mobile and video-specific needs. AcuityAds empowers marketers by offering transparency on costs and brand safety, and real-time reporting and analytics, bringing accountability to programmatic advertising to deliver business results.
AcuityAds is headquartered in Toronto, Canada with sales offices in New York City, Boston, Chicago, Los Angeles, San Francisco, San Diego, Dallas, Vancouver, Calgary, Montreal and London, England. For more information, visit AcuityAds.com.
Disclaimer in regards to Forward-looking Statements
Certain statements included herein constitute "forward-looking statements" within the meaning of applicable securities laws. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management at this time, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Investors are cautioned not to put undue reliance on forward-looking statements. Except as required by law, AcuityAds does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events. The Company's client that has been mentioned in this press release has the right to exercise an out clause right at any time during the advertising campaign.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE AcuityAds Inc.
For further information: Babak Pedram, Investor Relations, Virtus Advisory Group Inc., 416-644-5081, firstname.lastname@example.org; Tal Hayek, Chief Executive Officer, AcuityAds Holdings Inc., 416-218-9888, email@example.com